Location History:
- Quincy, MA (US) (2016)
- Walpole, MA (US) (2019)
Company Filing History:
Years Active: 2016-2019
Title: Innovations in Imaging: The Contributions of Danielle Rand
Introduction
Danielle Rand is an accomplished inventor based in Walpole, MA (US). She has made significant contributions to the field of imaging technology, particularly through her innovative patents. With a total of 2 patents, her work focuses on enhancing imaging techniques for medical applications.
Latest Patents
Rand's latest patents include a groundbreaking method and agent for protein-based nanobubble x-ray imaging. This invention employs protein shells, such as ferritin or viral capsid shells, referred to as nanobubbles, to improve x-ray images of cells or body tissues. The nanobubbles, which are sub-micron in size, can be functionalized for effective delivery to target tissues, either in vivo or in cell cultures. These hollow nanobubbles have a central core that may be empty or filled with a fluid, allowing them to form long-lived bubbles in the imaging environment. Their low electron density and distinct scattering properties enhance the visualization of tissue regions containing the shells. Additionally, Rand's work includes methods, compositions, and kits for imaging cells and tissues using nanoparticles and spatial frequency heterodyne imaging.
Career Highlights
Throughout her career, Danielle Rand has worked with prestigious institutions, including Brown University and Montana State University. Her research has focused on developing advanced imaging techniques that have the potential to revolutionize medical diagnostics.
Collaborations
Rand has collaborated with notable colleagues, including Christoph Rose-Petruck and Trevor Douglas, contributing to the advancement of imaging technologies.
Conclusion
Danielle Rand's innovative work in protein-based nanobubble x-ray imaging represents a significant advancement in medical imaging technology. Her contributions have the potential to enhance diagnostic capabilities and improve patient outcomes.